Top 10 Nanotech Capital Raises and Investors in the U.S. – January 1st – March 31st, 2026
Several interesting transactions closed in the Nanotech sector over the past quarter. If you would like more info on these deals or would like to discuss the capital raising market for your company, please contact me.
PIPE
- Clene, a pharmaceutical company that discovers, develops, and commercializes novel clean-surfaced nanotechnology therapeutics, received $6.03 million of development capital.
Merger/Acquisition
- Avidity Biosciences, a biopharmaceutical company that delivers Antibody Oligonucleotide Conjugates, a new class of RNA therapeutics, was acquired by Novartis for $11.33 billion.
Later Stage
- Atom Computing, develops quantum computers for scientific and industrial purposes, raised $182 million of venture funding in a deal led by Third Point Ventures.
- Cognito Therapeutics, digital therapeutics that treat neurodegenerative disorders by modulating brain activity and targeting underlying disease mechanisms associated with cognitive decline, raised $105 million of Series C venture funding in a deal led by Morningside Group, Starbloom Capital, and IAG Capital Partners.
- Coreshell, advanced battery components that enhance the performance and efficiency of energy storage systems, raised $46.30 million of Series B1 venture funding from Ferroglobe and GM Ventures.
- Utility Global, clean energy generation systems that reduce emissions, produce hydrogen, and improve productivity, raised $100 million of Series D venture funding in a deal led by Ara Partners, and APG Group.
Early Stage VC
- Averna Therapeutics, genomic medicine that transforms the treatment of a broad range of diseases, raised $85 million of Series A venture funding in a deal led by Novartis Venture Fund and Delos Capital Partners.
- SoFab Inks, perovskite solar cell manufacturing platform that offers functionalized materials for perovskite solar cells, raised $5.90 million of venture funding.
- SPhotonix, advanced optical devices that improve imaging, sensing, and communication systems, raised $4 million of venture funding in the form of convertible debt in a deal led by XTX Ventures and Creator Fund.
Seed Round
- CellMo Materials Innovation, metal foam materials for industrial and manufacturing applications in energy and thermal management sectors, raised $5.72 million of Seed-4 funding.
#castleplacement #capitalraising #privateequity #venturecapital #investment #nanotech
Jesus Tueme
Managing Director
Finance and banking executive with a global perspective, broad professional practice and extensive network in Latin America. 22 years at BBVA, BNPP and Credit Agricole. Successful deal-making track record with multinationals, major Latin American issuers and government agencies. Extensive experience in restructuring/special situations, initial public offerings, corporate strategy, evaluating alliances, mergers and acquisitions, corporate governance, risk management, customer centric and digital strategies, and financial analytics. BS in Economics from Mexico Monterrey Institute of Technology. MBA from the University of California Los Angeles in 1987. Graduated from Harvard Business School General Management Program. Further academic work on Risk Management at Stanford University and as a research and finance scholar at the Monterrey Institute of Technology.
- Email: jtueme@castleplacement.com
- (C) (646) 479-7616
Jesus Tueme
Managing Director
Please contact me if you have any questions or would like to discuss your capital raise:
Email: jtueme@castleplacement.com
(C) (646) 479-7616
Send us a message:
Sources: Information on this page was derived from a variety of sources including Bloomberg, Company Websites, Crunchbase, PitchBook and other news outlets. Castle Placement® does not warrant or guarantee this information, nor makes any representations as to the accuracy of the information. For more Risks, see CPGO Risks and Disclaimers.
